Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade GliomasScott Ryall, Cynthia Hawkins, Sanja Pajovic et al.|Cancer Cell|2020Cited by 470
MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemiaCourtney L. Jones, William L. Carroll, Christy M. Gearheart et al.|Blood|2015Cited by 103
CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profilesPayal Jain, Angela J. Waanders|Oncogene|2017Cited by 75
HGG-32. PNOC008: A PILOT TRIAL TESTING THE CLINICAL BENEFIT OF USING MOLECULAR PROFILING TO DETERMINE AN INDIVIDUALIZED TREATMENT PLAN IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMA (EXCLUDING DIFFUSE INTRINSIC PONTINE GLIOMA)Andrea Franson, Sabine Mueller, Lindsay Kilburn et al.|Neuro-Oncology|2024Cited by 2